Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

Clinical trial NCT05459415 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05459415
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck Neoadjuvant Therapy Resection Margin

Start date: 2022-06-22
Primary completion: 2025-06-21
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.